REPORT ON CARDIOPULMONARY EXERCISE TESTING Template

Date of test: 2023-10-15  Hospital Number: 123456  Patient Name: SMITH, John Date of Birth: 1975-06-20   Age: 48   Gender: Male Weight: 82 kg   Height: 1.78 m Written consent: consent obtained
INDICATION: shortness of breath, surgical risk evaluation
DIAGNOSES  COPD, high blood pressure, type 2 diabetes
MEDICATION: salbutamol 100mcg as needed, metformin 500mg twice daily, lisinopril 10mg once daily, atorvastatin 20mg at night, aspirin 75mg once daily
RESTING ECG: normal sinus rhythm  ECHOCARDIOGRAM: normal left ventricular function, ECHO date: 2023-09-30
Hb (g/dL): 14.2  Date of Hb: 2023-10-10
LUNG FUNCTION:  FEV1 (L): 2.5,  FEV1 (% predicted): 75%, FVC (L): 3.2, FEV1/FVC ratio: 0.78 Estimated MVV (L/min): 100 TLCOc (% predicted): 60%, KCOc (% predicted): 70%
PRE-CPET DISCUSSION: Patient reports increased breathlessness over the past 6 months, history of smoking 20 pack-years, quit 5 years ago.
TEST PROTOCOL Subject pedalled at 60rpm for 3 mins on Ergoline cycle ergometer without added load and then underwent incremental work rate increase at ramp 15 watts to symptom limiting maximum.
ECG changes: no significant changes Motivation: good effort Reason for termination: leg fatigue Borg dyspnoea score peak exercise: 7 Other symptoms reported: mild dizziness
SUMMARY: The exercise test demonstrated reduced exercise capacity with early onset of dyspnoea and leg fatigue. Oxygen saturation remained stable throughout the test. No significant ECG changes were noted during exercise.
PLAN: Advise patient to continue current medication regimen, refer to pulmonary rehabilitation program, follow up in 3 months for reassessment.
s10.ai